Table 2.
Drug Group | Volume (Million DDDs) | Expenditures (Million RMB) | ||||
---|---|---|---|---|---|---|
2018 | 2019 | YoY GR (%) | 2018 | 2019 | YoY GR (%) | |
“4 + 7” policy-related | 65.0 | 113.0 | 73.8 | 463.4 | 292.2 | −36.9 |
Generic | 22.8 | 95.3 | 318.0 | 101.9 | 145.5 | 42.8 |
Branded | 42.2 | 17.7 | −58.1 | 361.5 | 146.7 | −59.4 |
Basic alternatives | 29.6 | 37.3 | 26.0 | 103.5 | 128.9 | 24.6 |
Generic | 13.4 | 16.4 | 22.4 | 39.9 | 48.5 | 21.6 |
Branded | 16.2 | 20.9 | 29.0 | 63.6 | 80.4 | 26.4 |